Project HOPE (Hypertension Outreach Through Partnership and Engagement)
ConditionHypertension (HTN)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age25+
SponsorJohns Hopkins University
About this trial
The goal of this study is to learn if a nurse-led, task-shifting, community-based program can help lower blood pressure in adults aged 25 and older with uncontrolled high blood pressure (hypertension) in Monrovia, Liberia. The program is delivered through community-based mobile clinics by community health nurses (CHNs) trained in WHO-aligned hypertension care within the Ministry of Health's (MOH) Community Health hypertension management protocols.
Participants will:
* Receive blood pressure treatment from trained community health nurses (CHNs) at community-based mobile clinics in their communities, including medication and lifestyle counseling. * Complete surveys at their first visit, at 4 to 6 weeks, and at 3 months about their experience, satisfaction, and medication use. * Attend follow-up visits at the mobile clinic based on their blood pressure levels.
Community health nurses delivering the program will complete structured training and be invited to complete surveys before and after training, and to take part in interviews about their experience at the end of the study.
The study will take place over 7 months in five high-thoroughfare communities in Monrovia, Liberia, and aims to enroll 150 participants.
Eligibility criteria
Qualifiers
Adults aged ≥25 years
Systolic Blood Pressure (SBP) ≥160 mmHg at screening (Group A); OR
SBP 140-159 mmHg at screening with either documented elevation on more than one visit or a known history of hypertension (e.g., prior clinician diagnosis or current use of antihypertensive medication) (Group B)
Disqualifiers
<25 years of age
Hypertensive emergency with SBP ≥180 mmHg at screening (these patients will be referred to the nearest health center per local protocol; they may be re-screened for eligibility at a subsequent visit if SBP meets the inclusion criteria above)
Diagnosis of end-stage renal disease (ESRD)
Condition which interferes with outcome measurement (e.g., dialysis)
Trial design
Treatments tested in this trial
- Project HOPE Intervention
Treatment groups
150 Participants
are divided into 1 treatment groupLocations
1Wellness Partners Clinic MonroviaMontserrado County, Liberia
Sponsors and collaborators
Johns Hopkins University
Lead sponsor
Center for Advancing Health Systems Innovations (CAdHSI)
Collaborator
Wellness Partners Foundation
Collaborator
Source ClinicalTrials.gov